Knockdown of STAB1 inhibits AML cell line proliferation and growth in xenograft mice, possible via altering NF-κB pathway activity and has been suggested to increase AML cells sensitivity to venetoclax13,14. The gene discussed is STAB1; the disease is acute myeloid leukemia.